Metformin in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial

BACKGROUNDN Nonalcoholic steatohepatitis (NASH) is a common liver disease that can progress to cirrhosis or hepatocellular carcinoma. It is estimated that up to 3% of the Iranian population have this condition. Although the pathogenesis of NASH is incompletely understood, there is significant eviden...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazemi, Rozana, Aduli, Mohsen, Sotoudeh, Masoud, Malekzadeh, Reza, Seddighi, Nahid, Sepanlou, Sadaf Ghajarieh, Merat, Shahin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Association of Gastroerterology and Hepatology 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017700/
https://www.ncbi.nlm.nih.gov/pubmed/24829630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017700/
https://www.ncbi.nlm.nih.gov/pubmed/24829630

Ejemplares similares